https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51967 Wed 28 Feb 2024 10:04:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43534 , weight change ΔW, ΔVROI, and Δϕn, were analyzed using the ranked-Pearson correlation. Results: No statistically significant correlation was found for age, gender and ΔW. was found to have clinically important correlation with functional MDADI (ρ = −0.39, P = 0.081). ΔVROI was found to have statistically significant correlation of 0.44, 0.47 and 0.44 with global, physical and functional MDADI (P-value < 0.05). Δϕn was found to have statistically significant ranked-correlation (−0.46, −0.46 and −0.45) with physical, functional and total MDADI (P-value < 0.05). Conclusion: A transit fluence based decision support metric (DSM) is statistically correlated with the dysphagia risk. It can not only be used as an early signal in assisting clinicians in the ART patient selection for replanning, but also lowers the resource barrier of ART implementation.]]> Wed 21 Sep 2022 11:32:28 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54671 Wed 13 Mar 2024 07:44:44 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:6972 Wed 11 Apr 2018 15:26:57 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17112 Wed 11 Apr 2018 13:30:06 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34063 Wed 06 Apr 2022 14:02:02 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49078 Wed 03 May 2023 16:15:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38467 Tue 28 Sep 2021 10:45:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51990 Tue 26 Sep 2023 10:53:57 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48570 Tue 21 Mar 2023 18:40:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54385 Tue 20 Feb 2024 20:46:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53364 Thu 23 Nov 2023 10:41:20 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11084 Sat 24 Mar 2018 10:33:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8650 Sat 24 Mar 2018 08:41:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8085 Sat 24 Mar 2018 08:34:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:2483 Sat 24 Mar 2018 08:27:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14678 Sat 24 Mar 2018 08:19:07 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12769 Sat 24 Mar 2018 08:18:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5098 Sat 24 Mar 2018 07:48:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26864 4 aeroallergens in 47 % (33/70) and reactions to any food allergen in 63 % (50/80) of patients. There was no evidence of monthly concentration of symptomatic esophageal eosinophilia diagnosis in the subgroups of patients with any positive aeroallergen, >4 positive aeroallergens, or history of atopy. The diagnosis of symptomatic esophageal eosinophilia is not made more frequently in the summer months.]]> Sat 24 Mar 2018 07:41:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28777 11 mmol/l), and swallowing dysfunction in intervention stroke units. Results: Data from 1804 patients (718 preintervention; 1086 postintervention) showed that significantly more patients admitted to hospitals allocated to the intervention group received care according to the fever (n = 186 of 603, 31% vs. n = 74 of 483, 15%, P < 0·001), hyperglycemia (n = 22 of 603, 3·7% vs. n = 3 of 483, 0·6%, P = 0·01), and swallowing dysfunction protocols (n = 241 of 603, 40% vs. n = 19 of 483, 4·0%, P ≤ 0·001). Significantly more patients in these intervention stroke units received four-hourly temperature monitoring (n = 222 of 603, 37% vs. n = 90 of 483, 19%, P < 0·001) and six-hourly glucose monitoring (194 of 603, 32% vs. 46 of 483, 9·5%, P < 0·001) within 72 hours of admission to a stroke unit, and a swallowing screen (242 of 522, 46% vs. 24 of 350, 6·8%, P ≤ 0·0001) within the first 24 hours of admission to hospital. There was no difference between the groups in the treatment of patients with fever with paracetamol (22 of 105, 21% vs. 38 of 131, 29%, P = 0·78) or their hyperglycemia with insulin (40 of 100, 40% vs. 17 of 57, 30%, P = 0·49). Interpretation Our intervention resulted in better protocol adherence in intervention stroke units, which explains our main trial findings of improved patient 90-day outcomes. Although monitoring practices significantly improved, there was no difference between the groups in the treatment of fever and hyperglycemia following acute stroke. A significant link between improved treatment practices and improved outcomes would have explained further the success of our intervention, and we are still unable to explain definitively the large improvements in death and dependency found in the main trial results. One potential explanation is that improved monitoring may have led to better overall surveillance of deteriorating patients and faster initiation of treatments not measured as part of the main trial.]]> Sat 24 Mar 2018 07:23:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23236 Sat 24 Mar 2018 07:10:39 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52314 Mon 09 Oct 2023 10:24:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55168 Fri 19 Apr 2024 08:27:56 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38251 P <.004 and P =.006, respectively), diet modification (P <.001 both), and poorer patient-reported outcomes (P =.037 and P =.014, respectively). Conclusion: Increased swallowing issues can be expected in patients presenting with more severe external HNL and/or internal HNL following HNC treatment.]]> Fri 16 Feb 2024 15:08:00 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19834 Fri 14 Aug 2015 13:26:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54696 Fri 08 Mar 2024 12:07:07 AEDT ]]>